During the past decade, Hungarian Institute of Cardiology conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 4 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hungarian Institute of Cardiology" #1 sponsor was "Boehringer Ingelheim" with 2 trials, followed by "Boston Scientific Corporation" with 2 trials sponsored, "Hungarian Institute of Cardiology" with 2 trials sponsored, "Onze Lieve Vrouw Hospital" with 1 trials sponsored and "Semmelweis University Heart and Vascular Center" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hungarian Institute of Cardiology" #1 collaborator was "Abbott Medical Devices" with 1 trials as a collaborator, "Catharina Ziekenhuis Eindhoven" with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Genae" with 1 trials as a collaborator and "Golden Jubilee National Hospital" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Hungarian Institute of Cardiology" are "Heart Failure" (2 trials), "Aortic Valve Stenosis" (1 trials), "Atrial Fibrillation" (1 trials), "Body Composition" (1 trials) and "Cachexia" (1 trials). Many other conditions were trialed in "Hungarian Institute of Cardiology" in a lesser frequency.

Most popular intervention types in "Hungarian Institute of Cardiology" are "Device" (5 trials), "Drug" (2 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Aspirin" (1 trials), "CABG" (1 trials), "COGNIS CRT-D" (1 trials), "CRT-D" (1 trials) and "Clopidogrel or Ticagrelor" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hungarian Institute of Cardiology" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Hungarian Institute of Cardiology". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hungarian Institute of Cardiology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hungarian Institute of Cardiology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 2 trials that are defined as “Not Applicable".